Autonomic Nervous System - Part 1: Sympathetic System

Overview of the Nervous System

  • General Functions: The nervous system functions to control and coordinate the activity of every system within the body.
  • Control Mechanisms: It operates through both involuntary and voluntary control mechanisms.
  • Two Major Subdivisions:
    • Central Nervous System (CNS):
      • Composition: Composed of the brain and the spinal cord.
      • Function: Receives and interprets sensory information and initiates the appropriate motor responses.
    • Peripheral Nervous System (PNS):
      • Afferent Nerves: These carry sensory impulses toward the CNS.
      • Efferent Nerves: These carry motor impulses away from the CNS to the rest of the body.
      • Cranial Nerves: Consists of 1212 pairs.
      • Spinal Nerves: Consists of 3131 pairs.

Functional Divisions of the Peripheral Nervous System

  • Somatic Nervous System (SNS):
    • Anatomy: The nerves branch from cranial and spinal motor nerves.
    • Target: Innervates skeletal muscle.
    • Control: Responsible for voluntary control mediated by the cerebral cortex.
  • Autonomic Nervous System (ANS) - Visceral:
    • Anatomy: Branches of cranial and spinal motor nerves.
    • Target: Innervates cardiac muscle, smooth muscle of internal organs, and glands.
    • Control: Involuntary control regulated by the hypothalamus and the medulla oblongata.
    • Autorhythmicity: The capacity for contraction without any external stimulus.
    • Homeostasis: The ANS regulates the rate at which internal organs work by increasing or decreasing their activity to maintain a stable internal environment.

Structure and Synaptic Transmission of the ANS

  • Ganglia: These are collections of synapses where impulses travel from one neuron to the next. They serve as the junction between preganglionic and postganglionic nerves.
  • Preganglionic Nerve: This nerve fiber emerges directly from the spinal cord.
  • Postganglionic Nerve: This nerve fiber travels from the ganglion to the target internal organ or gland.
  • Neurotransmitters (NT): Chemical substances that keep the impulse going. They stimulate the internal organ or gland to produce a specific action or change by binding to specialized receptors.
  • Synaptic Arrangement by Division:
    • In both the Sympathetic and Parasympathetic divisions, the neurotransmitter released at the autonomic ganglion from the preganglionic fiber is Acetylcholine (ACH).
    • Parasympathetic Division: The postganglionic nerve fiber is cholinergic and releases ACH at the target organ.
    • Sympathetic Division: The postganglionic nerve fiber is adrenergic and releases Norepinephrine (NE) at the target organ.

Subdivisions of the Autonomic Nervous System

  • Sympathetic Nervous System:
    • Commonly referred to as the "Fight, Fright, or Flight" system.
    • Categorized as the Adrenergic system.
  • Parasympathetic Nervous System:
    • Commonly referred to as the "Rest and Digest" system.
    • Categorized as the Cholinergic system.
  • Dual Innervation: Most organs and glands receive nerves from both divisions to provide balanced regulation, with blood vessels being a notable exception (innervated primarily by the sympathetic system).

The Sympathetic Nervous System (Adrenergic System)

  • Primary Function: Regulates the activity of internal organs and glands during physical and mental stressful situations (focusing on the heart, brain, and lungs).
  • Energy Consumption: Involves the exertion of a large amount of physical and mental energy.
  • Body-Wide Response: A single neuron can act on many others; therefore, the whole body is typically stimulated simultaneously rather than just a single part.
  • Triggers: Daily stresses, illness, anxiety, and crisis situations.
  • Ganglionic Structure: The sympathetic ganglia are located far from the effector organs (closer to the spinal cord).
  • Endocrine Function: The adrenal medulla releases Epinephrine (EPI) and some Norepinephrine (NE) into the bloodstream to travel to receptor sites and produce systemic sympathetic responses.

Adrenergic Neurotransmitters and Synthesis

  • Acetylcholine (ACH): Cholinergic neurotransmitter released at the ganglia from presynaptic nerve endings in both the sympathetic and parasympathetic systems.
  • Norepinephrine (NE):
    • The primary adrenergic neurotransmitter released at postganglionic nerve endings.
    • Synthesized from Dopamine (DA).
    • Released by both neurons and the adrenal medulla.
  • Epinephrine (EPI):
    • Produced primarily by the adrenal medulla.
    • Acts on adrenergic receptors throughout the body.
  • Dopamine (DA):
    • Serves as a neurotransmitter in both the sympathetic system and the CNS.
    • Acts as the precursor to Norepinephrine (NE).
    • Stimulates multiple receptors including alpha, beta, and dopaminergic receptors; its specific actions are dose-dependent.
  • Synthesis Pathway:
    1. Tyrosine (Tyr) is taken up into the nerve ending.
    2. Tyrosine is enzymatically converted to dihydroxyphenylalanine (DOPA).
    3. DOPA is converted to Dopamine (DA).
    4. DA enters storage vesicles where it is synthesized into and stored as Norepinephrine (NE).
  • Fate of Norepinephrine after Release:
    • NE is released into the synaptic cleft upon adrenergic stimulation.
    • It can stimulate adrenergic receptors on target organs/glands.
    • It can stimulate alpha2\\alpha_2 receptors on the postganglionic nerve ending to inhibit further NE release (negative feedback).
    • It can undergo reuptake back into the nerve ending for restorage in vesicles or metabolism by Monoamine Oxidase (MAO) into inactive metabolites.

Detailed Classification of Adrenergic Receptors

  • Alpha-1 (alpha1\\alpha_1):
    • Location: Glands, smooth muscles, eyes, and most arteries and veins.
    • Effects: Smooth muscle contraction, vasoconstriction (leading to increased BP), and dilation of the pupils (mydriasis).
    • Stimulants: NE and EPI (catecholamines).
  • Alpha-2 (alpha2\\alpha_2):
    • Location: Adrenergic nerve endings.
    • Effects: Relaxation and inhibition. It produces a parasympathetic-like response by decreasing smooth muscle contraction (vasodilation, lowering BP).
    • Mechanism: Acts as a negative feedback system to decrease or regulate the release of NE.
  • Beta-1 (beta1\\beta_1):
    • Location: Primarily the heart.
    • Effects:
      • Positive Inotropic effect: Increased force of contraction.
      • Positive Chronotropic effect: Increased heart rate.
      • Positive Dromotropic effect: Increased conduction velocity.
    • Stimulants: NE and EPI (EPI has a stronger effect).
  • Beta-2 (beta2\\beta_2):
    • Location: Smooth muscle, lungs (bronchioles), uterus, skeletal muscle arteries, and coronary arteries.
    • Effects:
      • Smooth muscle relaxation.
      • Bronchodilation.
      • Uterine relaxation.
      • Vasodilation of coronary and skeletal muscle blood vessels.
    • Stimulants: Stimulated by EPI only; NE does not stimulate beta-2 receptors.

Physiologic Effects of Sympathetic Stimulation

  • Adrenal Medulla: Release of Epinephrine.
  • Arteries: General vasoconstriction. Exceptions include coronary arteries and skeletal muscle arteries, which undergo dilation via beta2\\beta_2 receptors.
  • Heart: Increased heart rate, increased AV conduction, and increased contractility.
  • Gastrointestinal (GI): Decreased GI motility and reduced secretions.
  • Eyes: Contraction of the iris muscle resulting in pupillary dilation (mydriasis).
  • Respiratory Passages: Bronchodilation.
  • Urinary System: Relaxation of the urinary bladder and contraction of the urinary sphincter, which decreases urination.
  • Metabolism: Conversion of glycogen to glucose to provide energy for use.

Sympathetic Effects on Blood Vessels and Vasomotor Tone

  • Vasoconstriction: Triggered by a high rate of sympathetic nerve firing. This increases blood pressure but reduces regional blood flow.
  • Vasodilation: Triggered by a low rate of sympathetic nerve firing (causing smooth muscle relaxation). This decreases blood pressure but increases blood flow through the vessels.
  • Note: BP is also regulated by other systems in the body besides vasomotor tone.

Pharmacology of the Sympathetic Nervous System

  • Sympathomimetic Effects: Occur when drugs mimic the sympathetic system. These are also known as adrenergics or adrenergic agonists.
  • Sympatholytic Effects: Occur when drugs work against the sympathetic system. These are known as adrenergic blocking drugs, adrenergic blockers, inhibitors, or antagonists.
Alpha-1 Adrenergic Agonists
  • Mechanism of Action (MOA): Stimulates the alpha1\\alpha_1 receptor, leading to smooth muscle contraction and vasoconstriction.
  • Clinical Uses:
    • Increasing circulation to vital organs.
    • Increasing blood pressure.
    • Decongestion (vasoconstriction of nasal passages shrinks swollen mucous membranes).
  • Cautions/Side Effects: Potential for excessive vasoconstriction in hypertensive or cardiac patients; slows digestion and urination; causes excessive nasal dryness.
General Adrenergic Agonists (e.g., Epinephrine)
  • MOA: Stimulates alpha1\\alpha_1, beta1\\beta_1, and beta2\\beta_2 receptors.
  • Clinical Profile: Functions as a vasopressor (increases BP), cardiac stimulant, and bronchodilator.
  • Uses: Severe allergic reactions (anaphylaxis), shock, and cardiac arrhythmias.
  • Examples: EpiPen Auto-Injectors (0.3 mg).
Alpha-1 Adrenergic Blocking Drugs
  • MOA: Binds to and blocks alpha1\\alpha_1 receptors, causing relaxation of smooth muscle and vasodilation.
  • Uses: Hypertension (HTN) and Benign Prostatic Hyperplasia (BPH) by increasing urine flow through ureter relaxation.
  • Suffix: Commonly end in "-azosin".
  • Side Effects: Orthostatic hypotension (caution with position changes), reflex tachycardia, GI upset, and increased urination.
Beta-1 Adrenergic Agonists
  • Dose-Dependent MOA:
    • Low Dose: Stimulates dopaminergic (D1D_1) receptors in kidneys, causing vasodilation and increased renal blood flow.
    • Moderate Dose: Stimulates beta1\\beta_1 receptors in the heart to increase contraction force and cardiac output.
    • High Dose: Stimulates alpha1\\alpha_1 receptors causing vasoconstriction and increased blood pressure.
  • Uses: Shock, acute heart failure.
  • Example: Dobutamine (250,mg/20,mL250\\,mg/20\\,mL).
  • Side Effects: Cardiac overstimulation and CNS irritation.
Beta-2 Adrenergic Agonists
  • MOA: Stimulates beta2\\beta_2 receptors to relax smooth muscle in the lungs and uterus.
  • Uses: Asthma, respiratory disease, and preterm labor.
  • Side Effects: Tachycardia, jitteriness, tremors, and headache.
Beta Blocking Drugs (Beta Blockers)
  • Suffix: Commonly end in "-olol".
  • Selective Beta-1 Blockers:
    • MOA: Block beta1\\beta_1 receptors. Produces negative inotropic (contraction), negative chronotropic (rate), and negative dromotropic (conduction) effects.
    • Uses: HTN, angina, arrhythmias, tachycardia, migraines, glaucoma (lowers IOP), and heart failure.
  • Non-selective Beta Blockers:
    • MOA: Block both beta1\\beta_1 and beta2\\beta_2 receptors.
    • Contraindication: Asthma and respiratory disease patients (can cause bronchoconstriction via beta2\\beta_2 blockade and trigger respiratory distress).
  • General Side Effects: Drowsiness, GI upset, CNS depression, bradycardia, mental depression; must monitor serum lipid levels and glucose levels in diabetics.